Gene · 6500
Papers4,444
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 4,444
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nrf2 in Cancer, Detoxifying Enzymes and Cell Death Programs. | Antioxidants (Basel) | 2021 | 34202320 | PubTator, text mining | PubMed |
| Regulation of the Human Papillomavirus Lifecyle through Post-Translational Modifications of the Viral E2 Protein. | Pathogens | 2021 | 34201556 | PubTator, text mining | PubMed |
| A Novel Signature of CCNF-Associated E3 Ligases Collaborate and Counter Each Other in Breast Cancer. | Cancers (Basel) | 2021 | 34201347 | PubTator, text mining | PubMed |
| Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway. | Int J Mol Sci | 2021 | 34198949 | PubTator, text mining | PubMed |
| The Multifaceted Role of HSF1 in Pathophysiology: Focus on Its Interplay with TG2. | Int J Mol Sci | 2021 | 34198675 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens reveal cyclin C as synthetic survival target of BRCA2. | Nucleic Acids Res | 2021 | 34197614 | PubTator, text mining | PubMed |
| Epigenetic Regulation of Autophagy Beyond the Cytoplasm: A Review. | Front Cell Dev Biol | 2021 | 34195194 | PubTator, text mining | PubMed |
| Comprehensive Analysis Reveals the Potential Regulatory Mechanism Between Ub-Proteasome System and Cell Cycle in Colorectal Cancer. | Front Cell Dev Biol | 2021 | 34195188 | PubTator, text mining | PubMed |
Comprehensive high-throughput meta-analysis of differentially expressed microRNAs in transcriptomic datasets reveals significant disruption of MAPK/JNK signal transduction pathway in Adult T-cell leukemia/lymphoma. | Infect Agent Cancer | 2021 | 34187521 | PubTator, text mining | PubMed |
| Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. | Environ Int | 2021 | 34186270 | PubTator, text mining | PubMed |
| CRY2 missense mutations suppress P53 and enhance cell growth. | Proc Natl Acad Sci U S A | 2021 | 34183418 | PubTator, text mining | PubMed |
| Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy. | Front Oncol | 2021 | 34178666 | PubTator, text mining | PubMed |
| Genome-wide identification and characterization of UBP gene family in wheat (Triticum aestivum L.). | PeerJ | 2021 | 34178465 | PubTator, text mining | PubMed |
| Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury. | World J Gastroenterol | 2021 | 34168400 | PubTator, text mining | PubMed |
| Attenuating glucose metabolism by Fbxw7 promotes Taxol sensitivity of colon cancer cells through downregulating NADPH oxidase 1 (Nox1). | Ann Transl Med | 2021 | 34164520 | PubTator, text mining | PubMed |
| E3 ubiquitin ligase Wwp1 regulates ciliary dynamics of the Hedgehog receptor Smoothened. | J Cell Biol | 2021 | 34161574 | PubTator, text mining | PubMed |
| Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer. | J Exp Clin Cancer Res | 2021 | 34154654 | PubTator, text mining | PubMed |
| Post-Translational Modifications in Oocyte Maturation and Embryo Development. | Front Cell Dev Biol | 2021 | 34150752 | PubTator, text mining | PubMed |
| Advancing targeted protein degradation for cancer therapy. | Nat Rev Cancer | 2021 | 34131295 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screen identifies protein pathways modulating tau protein levels in neurons. | Commun Biol | 2021 | 34127790 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6500/papers?page=57